1 April 2022 false No description of principal activity Taxfiler 2023.9 05381660business:PrivateLimitedCompanyLtd2022-04-012023-03-31 053816602022-03-31 053816602022-04-012023-03-31 05381660business:AuditExemptWithAccountantsReport2022-04-012023-03-31 05381660business:FilletedAccounts2022-04-012023-03-31 053816602023-03-31 05381660business:Director12022-04-012023-03-31 05381660business:Director22022-04-012023-03-31 05381660business:RegisteredOffice2022-04-012023-03-31 053816602022-03-31 05381660core:WithinOneYear2023-03-31 05381660core:WithinOneYear2022-03-31 05381660core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 05381660core:ShareCapitalcore:PreviouslyStatedAmount2022-03-31 05381660core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 05381660core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-03-31 05381660core:PreviouslyStatedAmount2023-03-31 05381660core:PreviouslyStatedAmount2022-03-31 05381660business:SmallEntities2022-04-012023-03-31 05381660countries:EnglandWales2022-04-012023-03-31 05381660core:ComputerEquipment2022-04-012023-03-31 05381660core:ComputerEquipment2022-03-31 05381660core:ComputerEquipment2023-03-31 05381660core:AfterOneYear2023-03-31 05381660core:AfterOneYear2022-03-31 05381660business:Director122022-04-012023-03-31 05381660business:Director122022-03-31 05381660business:Director122023-03-31 05381660business:Director212022-04-012023-03-31 05381660business:Director212022-03-31 05381660business:Director212023-03-31 053816602021-04-012022-03-31 iso4217:GBP xbrli:pure
Company Registration No. 05381660 (England and Wales)
Pharma QA Limited Unaudited accounts for the year ended 31 March 2023
Pharma QA Limited Unaudited accounts Contents
Page
- 2 -
Pharma QA Limited Company Information for the year ended 31 March 2023
Directors
Joanathan Mackney Mary Mackney
Company Number
05381660 (England and Wales)
Registered Office
10 HILL GARDENS STREATLEY READING RG8 9QF ENGLAND
Accountants
Glenton Smith Croft House Brightwell cum Sotwell Wallingford OXON OX10 0RJ
- 3 -
Pharma QA Limited Statement of financial position as at 31 March 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
513 
- 
Current assets
Debtors
46,203 
41,723 
Cash at bank and in hand
92,140 
121,085 
138,343 
162,808 
Creditors: amounts falling due within one year
(28,199)
(34,703)
Net current assets
110,144 
128,105 
Net assets
110,657 
128,105 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
110,557 
128,005 
Shareholders' funds
110,657 
128,105 
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 9 October 2023 and were signed on its behalf by
Mary Mackney Director Company Registration No. 05381660
- 4 -
Pharma QA Limited Notes to the Accounts for the year ended 31 March 2023
1
Statutory information
Pharma QA Limited is a private company, limited by shares, registered in England and Wales, registration number 05381660. The registered office is 10 HILL GARDENS, STREATLEY, READING, RG8 9QF, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% straight line
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
- 5 -
Pharma QA Limited Notes to the Accounts for the year ended 31 March 2023
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 April 2022
5,924 
Additions
649 
At 31 March 2023
6,573 
Depreciation
At 1 April 2022
5,924 
Charge for the year
136 
At 31 March 2023
6,060 
Net book value
At 31 March 2023
513 
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Trade debtors
14,153 
36,890 
Accrued income and prepayments
624 
315 
Other debtors
31,426 
178 
46,203 
37,383 
Amounts falling due after more than one year
Other debtors
- 
4,340 
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Trade creditors
1,068 
162 
Taxes and social security
25,731 
33,556 
Accruals
1,400 
985 
28,199 
34,703 
7
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Joanathan Mackney
Interest free loan, repayable on demand
- 
17,280 
- 
17,280 
Mary Mackney
Interest free loan, repayable on demand
178 
25,813 
16,085 
9,906 
178 
43,093 
16,085 
27,186 
8
Average number of employees
During the year the average number of employees was 2 (2022: 1).
- 6 -